Clinical Trials Logo

Filter by:
NCT ID: NCT05746663 Recruiting - Ankle Injuries Clinical Trials

A Morphological Study in Volleyball Athletes With Cronic Ankle Instability

Start date: February 20, 2023
Phase:
Study type: Observational [Patient Registry]

The former purpose of this study to investigate the effect of transverse abdominis, lumbar multifidus, vastus lateralis, lateral gastrocnemius, anterior talofibular ligament of morphology on explosive power and balance performance in cronic ankle instability with volleyball players. The latter purpose of this study to determine morphological characteristics volleyball players with and without cronic ankle insatbility of trunk muscle morphology, field tests and the muscle morphology features between the body affected and unaffected sides whose those with chronic ankle instability.This study was designed as a cross-sectional. Twelve volleyball players with chronic ankle instability who meet the criteria determined by the ankle consortium will be included in study group. Twelve asymptomatic volleyball players who have been training at least three days a week for at least one year will be include in the control group. They will consist of 24 volleyball players between 14-35 years of age.Morphological characteristics of anterior talofibular ligament, transverse abdominis, lumbar multifidus, vastus lateralis, lateral gastrocnemius will be evaluated via ultrasound, explosive power with squat jump, counter movement jump and balance performance by Y-Balance Test. Trunk muscle morphology, core stabilization, explosive power, balance performance will have been compered in volleyball players with and without chronic ankle instability. The effects of morphological features on explosive power and balance performance will have been determined. It is anticipated that by determining the parameters that can be affected by instability with volleyball players, it will guide the professionals working in the field, countribute to treatment and preventive treatment programs.

NCT ID: NCT05746559 Recruiting - Clinical trials for Chronic Kidney Disease

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

ARTEMIS
Start date: April 6, 2023
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac surgery with CPB.

NCT ID: NCT05746130 Completed - Adolescent Behavior Clinical Trials

Effect of Preventive Education on Reducing Urinary Bisphenol-A Levels in Adolescents

Start date: March 16, 2023
Phase: N/A
Study type: Interventional

It is known that Bisphenol-A (BPA) is the endocrine disrupting chemical that is most exposed by oral intake in daily life. Critical life periods when the sensitivity to these substances is known to be maximum; prenatal, postnatal and adolescence periods. The aim of this study is to compare the effects of plastic-free nutrition program, interactive education and BPA exposure feedback on urinary Bisphenol-A levels in adolescents with high use of packaged products.

NCT ID: NCT05745779 Completed - Clinical trials for Serum HbA1c and Vitamin D, Vitamin B12 Values in Periodontal Diseases

Vitamin D, HbA1c and Vitamin B12 Levels in Patients

Start date: August 11, 2022
Phase:
Study type: Observational

Abstract Aim: to compare the serum vitamin D, HbA1c and vitamin B12 levels in patients with gingivitis and four different periodontitis stages diagnosed according to the 2017 Periodontal Disease Classification. Materials and methods: A total of 606 (378 Female, 228 Male) patients were included in the study. The periodontal status of the patients was diagnosed with gingivitis, stage 1,2,3 and 4 periodontitis groups were formed. HbA1c, vitamin D and vitamin B12 values of the patients were compared and analyzed. Result: Conclusion:

NCT ID: NCT05745142 Completed - Clinical trials for Carcinoma, Renal Cell

A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

Start date: February 23, 2023
Phase:
Study type: Observational

The purpose of this study is to understand how patients with mRCC respond to the study medicine (called sunitinib) when they receive it as the first line of treatment after finding out the cause for the disease. This study will look into how different and how well groups of people with high chances of developing the disease respond to the study medicine. All data for this study will be anonymously extracted from data already entered in RCC Registry which is owned by Turkish Oncology Group Association (TOGD). This study will pull out records from the Registry between 01-Mar-2019 and 30-Oct-2022 that belongs to people: - who are Turkish citizens - who are older than 18 years - who were found out to have mRCC - who received sunitinib as the first line treatment after finding out the cause for the disease This study will look at the responses, experiences and how long the patients use the study medicine sunitinib.

NCT ID: NCT05744921 Recruiting - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works.

ACCESS-EXT
Start date: March 7, 2023
Phase: Phase 3
Study type: Interventional

This study is researching an experimental treatment combination with two experimental drugs called pozelimab and cemdisiran. The study is focused on patients with paroxysmal nocturnal hemoglobinuria (PNH). The aim of this study is to see how safe and effective the pozelimab + cemdisiran combination is for patients with PNH in the long term. The pozelimab + cemdisiran combination may be referred to as "study drugs" in this section. This study is looking at several other research questions, including: - How effective is the pozelimab + cemdisiran combination? - What side effects may happen from taking the study drugs? - How much of each study drug is in the blood at different times? - Whether the body makes antibodies against the study drugs (which could make the drugs less effective or could lead to side effects)

NCT ID: NCT05744908 Completed - Clinical trials for Chronic Interstitial Cystitis

Pentosan Polysulfate Treatment's Effectiveness

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To examine the relationship between symptoms and quality of life before and after oral pentosan polysulfate (PPS) treatment in cases diagnosed with interstitial cystitis/painful bladder syndrome (IC/BPS).

NCT ID: NCT05744778 Completed - Physical Therapy Clinical Trials

The Effect of Dry Needling Treatment Combined With Physical Therapy in Patients With Cervical Spondylosis

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

In this study, it was aimed to determine whether dry needling treatment applied to the trigger points in the trapezius muscle in patients with chronic neck pain due to cervical spondylosis makes an additional contribution to the treatment results of the physical therapy and rehabilitation program.

NCT ID: NCT05744765 Completed - Breathing, Mouth Clinical Trials

Effects of Breathing Exercises on Reaction Time

Start date: December 20, 2022
Phase: N/A
Study type: Interventional

The aim of the study was to investigate the short and long-term effects of breathing exercises on reaction time.

NCT ID: NCT05744544 Completed - Pain Clinical Trials

Sensory Assessment and Regression Rate of Bilateral External Oblique Intercostal Block and m-TAPA Block

Start date: May 2, 2023
Phase:
Study type: Observational [Patient Registry]

External oblique and m-tapa blocks are routinely performed on patients undergoing laparoscopic cholecystectomy in our clinic. In this study, sensory block and regression rates will be investigated in patients who underwent block.